{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:44:01Z","timestamp":1767894241414,"version":"3.49.0"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T00:00:00Z","timestamp":1469491200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170129"],"award-info":[{"award-number":["81170129"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"863 Program of China","award":["2011AA020110"],"award-info":[{"award-number":["2011AA020110"]}]},{"name":"863 Program of China","award":["2013AA020101"],"award-info":[{"award-number":["2013AA020101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s10741-016-9576-1","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T14:23:53Z","timestamp":1469543033000},"page":"737-752","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["New strategies for improving stem cell therapy in ischemic heart disease"],"prefix":"10.1007","volume":"21","author":[{"given":"Peisen","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaqiu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuejin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,7,26]]},"reference":[{"key":"9576_CR1","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.ijcard.2012.10.046","volume":"168","author":"JA Finegold","year":"2013","unstructured":"Finegold JA, Asaria P, Francis DP (2013) Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol 168:934\u2013945","journal-title":"Int J Cardiol"},{"key":"9576_CR2","unstructured":"http:\/\/www.who.int\/mediacentre\/factsheets\/fs310 . Accessed 19 Oct 2015"},{"key":"9576_CR3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","volume":"324","author":"O Bergmann","year":"2009","unstructured":"Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisen J (2009) Evidence for cardiomyocyte renewal in humans. Science 324:98\u2013102","journal-title":"Science"},{"key":"9576_CR4","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1327","volume":"25","author":"MA Laflamme","year":"2007","unstructured":"Laflamme MA, Chen KY, Naumova AV, Muskheli V, Fugate JA, Dupras SK, Reinecke H, Xu C, Hassanipour M, Police S, O\u2019Sullivan C, Collins L, Chen Y, Minami E, Gill EA, Ueno S, Yuan C, Gold J, Murry CE (2007) Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25:1015\u20131024","journal-title":"Nat Biotechnol"},{"key":"9576_CR5","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1161\/CIRCRESAHA.114.304792","volume":"117","author":"MR Afzal","year":"2015","unstructured":"Afzal MR, Samanta A, Shah ZI, Jeevanantham V, Abdel-Latif A, Zuba-Surma EK, Dawn B (2015) Adult bone marrow cell therapy for ischemic heart disease: evidence and insights from randomized controlled trials. Circ Res 117:558\u2013575","journal-title":"Circ Res"},{"key":"9576_CR6","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/CRD.0000000000000018","volume":"22","author":"RE Michler","year":"2014","unstructured":"Michler RE (2014) Stem cell therapy for heart failure. Cardiol Rev 22:105\u2013116","journal-title":"Cardiol Rev"},{"key":"9576_CR7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature07040","volume":"453","author":"R Passier","year":"2008","unstructured":"Passier R, van Laake LW, Mummery CL (2008) Stem-cell-based therapy and lessons from the heart. Nature 453:322\u2013329","journal-title":"Nature"},{"key":"9576_CR8","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1089\/scd.2011.0684","volume":"21","author":"Q Zhang","year":"2012","unstructured":"Zhang Q, Yang Y, Wang H, Dong Q, Wang T, Qian H, Xu H (2012) Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase\/mammalian target of rapamycin pathway. Stem Cells Dev 21:1321\u20131332","journal-title":"Stem Cells Dev"},{"key":"9576_CR9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.stem.2013.05.008","volume":"12","author":"JC Garbern","year":"2013","unstructured":"Garbern JC, Lee RT (2013) Cardiac stem cell therapy and the promise of heart regeneration. Cell Stem Cell 12:689\u2013698","journal-title":"Cell Stem Cell"},{"key":"9576_CR10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.108.176826","volume":"103","author":"M Gnecchi","year":"2008","unstructured":"Gnecchi M, Zhang Z, Ni A, Dzau VJ (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103:1204\u20131219","journal-title":"Circ Res"},{"key":"9576_CR11","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1253\/circj.CJ-11-1479","volume":"76","author":"SH Choi","year":"2012","unstructured":"Choi SH, Jung SY, Kwon S, Baek SH (2012) Perspectives on stem cell therapy for cardiac regeneration. Circ J 76:1307\u20131312","journal-title":"Circ J"},{"key":"9576_CR12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","volume":"117","author":"P Menasche","year":"2008","unstructured":"Menasche P, Alfieri O, Janssens S, McKenna W, Reichenspurner H, Trinquart L, Vilquin JT, Marolleau JP, Seymour B, Larghero J, Lake S, Chatellier G, Solomon S, Desnos M, Hagege AA (2008) The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 117:1189\u20131200","journal-title":"Circulation"},{"key":"9576_CR13","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0735-1097(03)00092-5","volume":"41","author":"P Menasche","year":"2003","unstructured":"Menasche P, Hagege AA, Vilquin JT, Desnos M, Abergel E, Pouzet B, Bel A, Sarateanu S, Scorsin M, Schwartz K, Bruneval P, Benbunan M, Marolleau JP, Duboc D (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 41:1078\u20131083","journal-title":"J Am Coll Cardiol"},{"key":"9576_CR14","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1161\/CIRCRESAHA.116.304386","volume":"116","author":"SA Fisher","year":"2015","unstructured":"Fisher SA, Doree C, Mathur A, Martin-Rendon E (2015) Meta-analysis of cell therapy trials for patients with heart failure. Circ Res 116:1361\u20131377","journal-title":"Circ Res"},{"key":"9576_CR15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","volume":"311","author":"AW Heldman","year":"2014","unstructured":"Heldman AW, DiFede DL, Fishman JE, Zambrano JP, Trachtenberg BH, Karantalis V, Mushtaq M, Williams AR, Suncion VY, McNiece IK, Ghersin E, Soto V, Lopera G, Miki R, Willens H, Hendel R, Mitrani R, Pattany P, Feigenbaum G, Oskouei B, Byrnes J, Lowery MH, Sierra J, Pujol MV, Delgado C, Gonzalez PJ, Rodriguez JE, Bagno LL, Rouy D, Altman P, Foo CW, Da SJ, Anderson E, Schwarz R, Mendizabal A, Hare JM (2014) Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA 311:62\u201373","journal-title":"JAMA"},{"key":"9576_CR16","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.jacc.2010.03.066","volume":"56","author":"A Behfar","year":"2010","unstructured":"Behfar A, Yamada S, Crespo-Diaz R, Nesbitt JJ, Rowe LA, Perez-Terzic C, Gaussin V, Homsy C, Bartunek J, Terzic A (2010) Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J Am Coll Cardiol 56:721\u2013734","journal-title":"J Am Coll Cardiol"},{"key":"9576_CR17","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","volume":"61","author":"J Bartunek","year":"2013","unstructured":"Bartunek J, Behfar A, Dolatabadi D, Vanderheyden M, Ostojic M, Dens J, El NB, Banovic M, Beleslin B, Vrolix M, Legrand V, Vrints C, Vanoverschelde JL, Crespo-Diaz R, Homsy C, Tendera M, Waldman S, Wijns W, Terzic A (2013) Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J Am Coll Cardiol 61:2329\u20132338","journal-title":"J Am Coll Cardiol"},{"key":"9576_CR18","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10741-015-9494-7","volume":"20","author":"J Ye","year":"2015","unstructured":"Ye J, Yeghiazarians Y (2015) Cardiac stem cell therapy: Have we put too much hype in which cell type to use? Heart Fail Rev 20:613\u2013619","journal-title":"Heart Fail Rev"},{"key":"9576_CR19","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663\u2013676","journal-title":"Cell"},{"key":"9576_CR20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.stem.2011.12.013","volume":"10","author":"PW Burridge","year":"2012","unstructured":"Burridge PW, Keller G, Gold JD, Wu JC (2012) Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 10:16\u201328","journal-title":"Cell Stem Cell"},{"key":"9576_CR21","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/CIRCRESAHA.110.240010","volume":"109","author":"RP Ahmed","year":"2011","unstructured":"Ahmed RP, Haider HK, Buccini S, Li L, Jiang S, Ashraf M (2011) Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart. Circ Res 109:60\u201370","journal-title":"Circ Res"},{"key":"9576_CR22","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1093\/eurheartj\/ehr166","volume":"32","author":"C Mauritz","year":"2011","unstructured":"Mauritz C, Martens A, Rojas SV, Schnick T, Rathert C, Schecker N, Menke S, Glage S, Zweigerdt R, Haverich A, Martin U, Kutschka I (2011) Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J 32:2634\u20132641","journal-title":"Eur Heart J"},{"key":"9576_CR23","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1161\/CIRCULATIONAHA.111.084343","volume":"126","author":"M Kawamura","year":"2012","unstructured":"Kawamura M, Miyagawa S, Miki K, Saito A, Fukushima S, Higuchi T, Kawamura T, Kuratani T, Daimon T, Shimizu T, Okano T, Sawa Y (2012) Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model. Circulation 126:S29\u2013S37","journal-title":"Circulation"},{"key":"9576_CR24","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.112.000641","volume":"127","author":"Q Xiong","year":"2013","unstructured":"Xiong Q, Ye L, Zhang P, Lepley M, Tian J, Li J, Zhang L, Swingen C, Vaughan JT, Kaufman DS, Zhang J (2013) Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling. Circulation 127:997\u20131008","journal-title":"Circulation"},{"key":"9576_CR25","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.stem.2014.11.009","volume":"15","author":"L Ye","year":"2014","unstructured":"Ye L, Chang Y, Xiong Q, Zhang P, Zhang L, Somasundaram P, Lepley M, Swingen C, Su L, Wendel JS, Guo J, Jang A, Rosenbush D, Greder L, Dutton JR, Zhang J, Kamp TJ, Kaufman DS, Ge Y, Zhang J (2014) Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. Cell Stem Cell 15:750\u2013761","journal-title":"Cell Stem Cell"},{"key":"9576_CR26","doi-asserted-by":"crossref","first-page":"e19012","DOI":"10.1371\/journal.pone.0019012","volume":"6","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Wang D, Chen M, Yang B, Zhang F, Cao K (2011) Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart. PLoS One 6:e19012","journal-title":"PLoS One"},{"key":"9576_CR27","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2217\/rme.10.103","volume":"6","author":"RP Ahmed","year":"2011","unstructured":"Ahmed RP, Ashraf M, Buccini S, Shujia J, Haider H (2011) Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction. Regen Med 6:171\u2013178","journal-title":"Regen Med"},{"key":"9576_CR28","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4161\/cc.27677","volume":"13","author":"L Zhang","year":"2014","unstructured":"Zhang L, Pan Y, Qin G, Chen L, Chatterjee TK, Weintraub NL, Tang Y (2014) Inhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: improving the safety of iPS cell transplantation to myocardium. Cell Cycle 13:762\u2013771","journal-title":"Cell Cycle"},{"key":"9576_CR29","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1089\/scd.2014.0259","volume":"23","author":"SP Wyles","year":"2014","unstructured":"Wyles SP, Yamada S, Oommen S, Maleszewski JJ, Beraldi R, Martinez-Fernandez A, Terzic A, Nelson TJ (2014) Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy. Stem Cells Dev 23:2274\u20132282","journal-title":"Stem Cells Dev"},{"key":"9576_CR30","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.hrthm.2010.09.006","volume":"7","author":"SY Liao","year":"2010","unstructured":"Liao SY, Liu Y, Siu CW, Zhang Y, Lai WH, Au KW, Lee YK, Chan YC, Yip PM, Wu EX, Wu Y, Lau CP, Li RA, Tse HF (2010) Proarrhythmic risk of embryonic stem cell-derived cardiomyocyte transplantation in infarcted myocardium. Heart Rhythm 7:1852\u20131859","journal-title":"Heart Rhythm"},{"key":"9576_CR31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature13233","volume":"510","author":"JJ Chong","year":"2014","unstructured":"Chong JJ, Yang X, Don CW, Minami E, Liu YW, Weyers JJ, Mahoney WM, Van Biber B, Cook SM, Palpant NJ, Gantz JA, Fugate JA, Muskheli V, Gough GM, Vogel KW, Astley CA, Hotchkiss CE, Baldessari A, Pabon L, Reinecke H, Gill EA, Nelson V, Kiem HP, Laflamme MA, Murry CE (2014) Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts. Nature 510:273\u2013277","journal-title":"Nature"},{"key":"9576_CR32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jacc.2014.04.056","volume":"64","author":"V Sanchez-Freire","year":"2014","unstructured":"Sanchez-Freire V, Lee AS, Hu S, Abilez OJ, Liang P, Lan F, Huber BC, Ong SG, Hong WX, Huang M, Wu JC (2014) Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells. J Am Coll Cardiol 64:436\u2013448","journal-title":"J Am Coll Cardiol"},{"key":"9576_CR33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/CIRCULATIONAHA.112.131110","volume":"127","author":"AR Williams","year":"2013","unstructured":"Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, Morales AR, Da SJ, Sussman MA, Heldman AW, Hare JM (2013) Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation 127:213\u2013223","journal-title":"Circulation"},{"key":"9576_CR34","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2015.08.879","volume":"66","author":"V Karantalis","year":"2015","unstructured":"Karantalis V, Suncion-Loescher VY, Bagno L, Golpanian S, Wolf A, Sanina C, Premer C, Kanelidis AJ, McCall F, Wang B, Balkan W, Rodriguez J, Rosado M, Morales A, Hatzistergos K, Natsumeda M, Margitich I, Schulman IH, Gomes SA, Mushtaq M, DiFede DL, Fishman JE, Pattany P, Zambrano JP, Heldman AW, Hare JM (2015) Synergistic effects of combined cell therapy for chronic ischemic cardiomyopathy. J Am Coll Cardiol 66:1990\u20131999","journal-title":"J Am Coll Cardiol"},{"key":"9576_CR35","doi-asserted-by":"crossref","first-page":"186","DOI":"10.5966\/sctm.2015-0101","volume":"5","author":"S Golpanian","year":"2016","unstructured":"Golpanian S, Schulman IH, Ebert RF, Heldman AW, DiFede DL, Yang PC, Wu JC, Bolli R, Perin EC, Moye L, Simari RD, Wolf A, Hare JM (2016) Concise review: review and perspective of cell dosage and routes of administration from preclinical and clinical studies of stem cell therapy for heart disease. Stem Cells Transl Med 5:186\u2013191","journal-title":"Stem Cells Transl Med"},{"key":"9576_CR36","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1161\/01.CIR.0000084828.50310.6A","volume":"108","author":"IM Barbash","year":"2003","unstructured":"Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA, Leor J (2003) Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108:863\u2013868","journal-title":"Circulation"},{"key":"9576_CR37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijcard.2005.07.036","volume":"111","author":"MJ Price","year":"2006","unstructured":"Price MJ, Chou CC, Frantzen M, Miyamoto T, Kar S, Lee S, Shah PK, Martin BJ, Lill M, Forrester JS, Chen PS, Makkar RR (2006) Intravenous mesenchymal stem cell therapy early after reperfused acute myocardial infarction improves left ventricular function and alters electrophysiologic properties. Int J Cardiol 111:231\u2013239","journal-title":"Int J Cardiol"},{"key":"9576_CR38","first-page":"512","volume":"45","author":"W Brenner","year":"2004","unstructured":"Brenner W, Aicher A, Eckey T, Massoudi S, Zuhayra M, Koehl U, Heeschen C, Kampen WU, Zeiher AM, Dimmeler S, Henze E (2004) 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model. J Nucl Med 45:512\u2013518","journal-title":"J Nucl Med"},{"key":"9576_CR39","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/scrt4","volume":"1","author":"VF Forest","year":"2010","unstructured":"Forest VF, Tirouvanziam AM, Perigaud C, Fernandes S, Fusellier MS, Desfontis JC, Toquet CS, Heymann MF, Crochet DP, Lemarchand PF (2010) Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials. Stem Cell Res Ther 1:4","journal-title":"Stem Cell Res Ther"},{"key":"9576_CR40","doi-asserted-by":"crossref","first-page":"H2670","DOI":"10.1152\/ajpheart.01071.2003","volume":"287","author":"N Nagaya","year":"2004","unstructured":"Nagaya N, Fujii T, Iwase T, Ohgushi H, Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K, Kitamura S (2004) Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 287:H2670\u2013H2676","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9576_CR41","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/CIRCULATIONAHA.105.537480","volume":"112","author":"DL Kraitchman","year":"2005","unstructured":"Kraitchman DL, Tatsumi M, Gilson WD, Ishimori T, Kedziorek D, Walczak P, Segars WP, Chen HH, Fritzges D, Izbudak I, Young RG, Marcelino M, Pittenger MF, Solaiyappan M, Boston RC, Tsui BM, Wahl RL, Bulte JW (2005) Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction. Circulation 112:1451\u20131461","journal-title":"Circulation"},{"key":"9576_CR42","first-page":"1058","volume":"7","author":"N Li","year":"2015","unstructured":"Li N, Yang YJ, Qian HY, Li Q, Zhang Q, Li XD, Dong QT, Xu H, Song L, Zhang H (2015) Intravenous administration of atorvastatin-pretreated mesenchymal stem cells improves cardiac performance after acute myocardial infarction: role of CXCR4. Am J Transl Res 7:1058\u20131070","journal-title":"Am J Transl Res"},{"key":"9576_CR43","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/eurheartj\/ehi818","volume":"27","author":"T Freyman","year":"2006","unstructured":"Freyman T, Polin G, Osman H, Crary J, Lu M, Cheng L, Palasis M, Wilensky RL (2006) A quantitative, randomized study evaluating three methods of mesenchymal stem cell delivery following myocardial infarction. Eur Heart J 27:1114\u20131122","journal-title":"Eur Heart J"},{"key":"9576_CR44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cardfail.2009.12.006","volume":"16","author":"M Rigol","year":"2010","unstructured":"Rigol M, Solanes N, Farre J, Roura S, Roque M, Berruezo A, Bellera N, Novensa L, Tamborero D, Prat-Vidal C, Huzman MA, Batlle M, Hoefsloot M, Sitges M, Ramirez J, Dantas AP, Merino A, Sanz G, Brugada J, Bayes-Genis A, Heras M (2010) Effects of adipose tissue-derived stem cell therapy after myocardial infarction: impact of the route of administration. J Card Fail 16:357\u2013366","journal-title":"J Card Fail"},{"key":"9576_CR45","first-page":"I150","volume":"112","author":"D Hou","year":"2005","unstructured":"Hou D, Youssef EA, Brinton TJ, Zhang P, Rogers P, Price ET, Yeung AC, Johnstone BH, Yock PG, March KL (2005) Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials. Circulation 112:I150\u2013I156","journal-title":"Circulation"},{"key":"9576_CR46","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/CIRCRESAHA.114.303180","volume":"114","author":"V Karantalis","year":"2014","unstructured":"Karantalis V, DiFede DL, Gerstenblith G, Pham S, Symes J, Zambrano JP, Fishman J, Pattany P, McNiece I, Conte J, Schulman S, Wu K, Shah A, Breton E, Davis-Sproul J, Schwarz R, Feigenbaum G, Mushtaq M, Suncion VY, Lardo AC, Borrello I, Mendizabal A, Karas TZ, Byrnes J, Lowery M, Heldman AW, Hare JM (2014) Autologous mesenchymal stem cells produce concordant improvements in regional function, tissue perfusion, and fibrotic burden when administered to patients undergoing coronary artery bypass grafting: the Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS) trial. Circ Res 114:1302\u20131310","journal-title":"Circ Res"},{"key":"9576_CR47","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","volume":"308","author":"JM Hare","year":"2012","unstructured":"Hare JM, Fishman JE, Gerstenblith G, DiFede VD, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J, Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong PFC, Ruiz P, Amador A, Da SJ, McNiece IK, Heldman AW, George R, Lardo A (2012) Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 308:2369\u20132379","journal-title":"JAMA"},{"key":"9576_CR48","first-page":"II219","volume":"110","author":"K Suzuki","year":"2004","unstructured":"Suzuki K, Murtuza B, Beauchamp JR, Brand NJ, Barton PJ, Varela-Carver A, Fukushima S, Coppen SR, Partridge TA, Yacoub MH (2004) Role of interleukin-1beta in acute inflammation and graft death after cell transplantation to the heart. Circulation 110:II219\u2013II224","journal-title":"Circulation"},{"key":"9576_CR49","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1006\/jmcc.2001.1367","volume":"33","author":"M Zhang","year":"2001","unstructured":"Zhang M, Methot D, Poppa V, Fujio Y, Walsh K, Murry CE (2001) Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol 33:907\u2013921","journal-title":"J Mol Cell Cardiol"},{"key":"9576_CR50","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.RES.0000118601.37875.AC","volume":"94","author":"T Kinnaird","year":"2004","unstructured":"Kinnaird T, Stabile E, Burnett MS, Lee CW, Barr S, Fuchs S, Epstein SE (2004) Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ Res 94:678\u2013685","journal-title":"Circ Res"},{"key":"9576_CR51","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.3727\/096368911X623916","volume":"21","author":"P Fidelis-de-Oliveira","year":"2012","unstructured":"Fidelis-de-Oliveira P, Werneck-de-Castro JP, Pinho-Ribeiro V, Shalom BC, Nascimento-Silva JH, Costa ESR, Cruz IS, Rangel RR, Goldenberg RC, Campos-de-Carvalho AC (2012) Soluble factors from multipotent mesenchymal stromal cells have antinecrotic effect on cardiomyocytes in vitro and improve cardiac function in infarcted rat hearts. Cell Transplant 21:1011\u20131021","journal-title":"Cell Transplant"},{"key":"9576_CR52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCRESAHA.116.304360","volume":"116","author":"WD Gray","year":"2015","unstructured":"Gray WD, French KM, Ghosh-Choudhary S, Maxwell JT, Brown ME, Platt MO, Searles CD, Davis ME (2015) Identification of therapeutic covariant MicroRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology. Circ Res 116:255\u2013263","journal-title":"Circ Res"},{"key":"9576_CR53","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jacc.2007.06.009","volume":"50","author":"CD Kan","year":"2007","unstructured":"Kan CD, Li SH, Weisel RD, Zhang S, Li RK (2007) Recipient age determines the cardiac functional improvement achieved by skeletal myoblast transplantation. J Am Coll Cardiol 50:1086\u20131092","journal-title":"J Am Coll Cardiol"},{"key":"9576_CR54","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jtcvs.2009.08.052","volume":"139","author":"Y Zhuo","year":"2010","unstructured":"Zhuo Y, Li SH, Chen MS, Wu J, Kinkaid HY, Fazel S, Weisel RD, Li RK (2010) Aging impairs the angiogenic response to ischemic injury and the activity of implanted cells: combined consequences for cell therapy in older recipients. J Thorac Cardiovasc Surg 139:1286\u20131294 1294.e1\u20132","journal-title":"J Thorac Cardiovasc Surg"},{"key":"9576_CR55","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.ajpath.2012.08.021","volume":"181","author":"KR Brunt","year":"2012","unstructured":"Brunt KR, Zhang Y, Mihic A, Li M, Li SH, Xue P, Zhang W, Basmaji S, Tsang K, Weisel RD, Yau TM, Li RK (2012) Role of WNT\/beta-catenin signaling in rejuvenating myogenic differentiation of aged mesenchymal stem cells from cardiac patients. Am J Pathol 181:2067\u20132078","journal-title":"Am J Pathol"},{"key":"9576_CR56","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.jacc.2012.08.985","volume":"60","author":"K Kang","year":"2012","unstructured":"Kang K, Sun L, Xiao Y, Li SH, Wu J, Guo J, Jiang SL, Yang L, Yau TM, Weisel RD, Radisic M, Li RK (2012) Aged human cells rejuvenated by cytokine enhancement of biomaterials for surgical ventricular restoration. J Am Coll Cardiol 60:2237\u20132249","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"9576_CR57","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.3760\/cma.j.issn.0366-6999.20132638","volume":"127","author":"N Li","year":"2014","unstructured":"Li N, Zhang Q, Qian H, Jin C, Yang Y, Gao R (2014) Atorvastatin induces autophagy of mesenchymal stem cells under hypoxia and serum deprivation conditions by activating the mitogen-activated protein kinase\/extracellular signal-regulated kinase pathway. Chin Med J 127(6):1046\u20131051","journal-title":"Chin Med J"},{"key":"9576_CR58","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/mt.2010.160","volume":"18","author":"L Drowley","year":"2010","unstructured":"Drowley L, Okada M, Beckman S, Vella J, Keller B, Tobita K, Huard J (2010) Cellular antioxidant levels influence muscle stem cell therapy. Mol Ther 18:1865\u20131873","journal-title":"Mol Ther"},{"key":"9576_CR59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/j.semtcvs.2008.04.001","volume":"20","author":"PW Fedak","year":"2008","unstructured":"Fedak PW (2008) Paracrine effects of cell transplantation: modifying ventricular remodeling in the failing heart. Semin Thorac Cardiovasc Surg 20:87\u201393","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"9576_CR60","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.jvs.2009.05.049","volume":"50","author":"JX Yu","year":"2009","unstructured":"Yu JX, Huang XF, Lv WM, Ye CS, Peng XZ, Zhang H, Xiao LB, Wang SM (2009) Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization. J Vasc Surg 50:608\u2013616","journal-title":"J Vasc Surg"},{"key":"9576_CR61","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1016\/j.jacc.2010.11.069","volume":"57","author":"J Roncalli","year":"2011","unstructured":"Roncalli J, Renault MA, Tongers J, Misener S, Thorne T, Kamide C, Jujo K, Tanaka T, Ii M, Klyachko E, Losordo DW (2011) Sonic hedgehog-induced functional recovery after myocardial infarction is enhanced by AMD3100-mediated progenitor-cell mobilization. J Am Coll Cardiol 57:2444\u20132452","journal-title":"J Am Coll Cardiol"},{"key":"9576_CR62","doi-asserted-by":"crossref","first-page":"S247","DOI":"10.1161\/CIRCULATIONAHA.108.843680","volume":"120","author":"T Deuse","year":"2009","unstructured":"Deuse T, Peter C, Fedak PW, Doyle T, Reichenspurner H, Zimmermann WH, Eschenhagen T, Stein W, Wu JC, Robbins RC, Schrepfer S (2009) Hepatocyte growth factor or vascular endothelial growth factor gene transfer maximizes mesenchymal stem cell-based myocardial salvage after acute myocardial infarction. Circulation 120:S247\u2013S254","journal-title":"Circulation"},{"key":"9576_CR63","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCRESAHA.112.266015","volume":"111","author":"AR Mackie","year":"2012","unstructured":"Mackie AR, Klyachko E, Thorne T, Schultz KM, Millay M, Ito A, Kamide CE, Liu T, Gupta R, Sahoo S, Misener S, Kishore R, Losordo DW (2012) Sonic hedgehog-modified human CD34+ cells preserve cardiac function after acute myocardial infarction. Circ Res 111:312\u2013321","journal-title":"Circ Res"},{"key":"9576_CR64","doi-asserted-by":"crossref","first-page":"e005652","DOI":"10.1161\/JAHA.112.005652","volume":"1","author":"M Mathison","year":"2012","unstructured":"Mathison M, Gersch RP, Nasser A, Lilo S, Korman M, Fourman M, Hackett N, Shroyer K, Yang J, Ma Y, Crystal RG, Rosengart TK (2012) In vivo cardiac cellular reprogramming efficacy is enhanced by angiogenic preconditioning of the infarcted myocardium with vascular endothelial growth factor. J Am Heart Assoc 1:e005652","journal-title":"J Am Heart Assoc"},{"key":"9576_CR65","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/imi.0b013e318265d9f6","volume":"7","author":"TK Rosengart","year":"2012","unstructured":"Rosengart TK, Fallon E, Crystal RG (2012) Cardiac biointerventions: Whatever happened to stem cell and gene therapy? Innovations 7:173\u2013179","journal-title":"Innovations"},{"key":"9576_CR66","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.biomaterials.2015.12.025","volume":"82","author":"HK Awada","year":"2016","unstructured":"Awada HK, Hwang MP, Wang Y (2016) Towards comprehensive cardiac repair and regeneration after myocardial infarction: aspects to consider and proteins to deliver. Biomaterials 82:94\u2013112","journal-title":"Biomaterials"},{"key":"9576_CR67","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.pharmthera.2012.07.005","volume":"136","author":"SG Ong","year":"2012","unstructured":"Ong SG, Hausenloy DJ (2012) Hypoxia-inducible factor as a therapeutic target for cardioprotection. Pharmacol Ther 136:69\u201381","journal-title":"Pharmacol Ther"},{"key":"9576_CR68","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1161\/CIRCULATIONAHA.113.007917","volume":"130","author":"SG Ong","year":"2014","unstructured":"Ong SG, Lee WH, Huang M, Dey D, Kodo K, Sanchez-Freire V, Gold JD, Wu JC (2014) Cross talk of combined gene and cell therapy in ischemic heart disease: role of exosomal MicroRNA transfer. Circulation 130:S60\u2013S69","journal-title":"Circulation"},{"issue":"Supplement 2","key":"9576_CR69","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0092-8674(04)00035-2","volume":"116","author":"R Lee","year":"2004","unstructured":"Lee R, Feinbaum R, Ambros V (2004) A short history of a short RNA. Cell 116(Supplement 2):S89\u2013S92","journal-title":"Cell"},{"issue":"2","key":"9576_CR70","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrm2621","volume":"10","author":"VK Gangaraju","year":"2009","unstructured":"Gangaraju VK, Lin H (2009) MicroRNAs: key regulators of stem cells. Nat Rev Mol Cell Biol 10(2):116\u2013125","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9576_CR71","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1161\/CIRCULATIONAHA.112.093906","volume":"126","author":"P Jakob","year":"2012","unstructured":"Jakob P, Doerries C, Briand S, Mocharla P, Krankel N, Besler C, Mueller M, Manes C, Templin C, Baltes C, Rudin M, Adams H, Wolfrum M, Noll G, Ruschitzka F, Luscher TF, Landmesser U (2012) Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity. Circulation 126:2962\u20132975","journal-title":"Circulation"},{"key":"9576_CR72","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1161\/CIRCULATIONAHA.113.001720","volume":"128","author":"F Jansen","year":"2013","unstructured":"Jansen F, Yang X, Hoelscher M, Cattelan A, Schmitz T, Proebsting S, Wenzel D, Vosen S, Franklin BS, Fleischmann BK, Nickenig G, Werner N (2013) Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation 128:2026\u20132038","journal-title":"Circulation"},{"key":"9576_CR73","doi-asserted-by":"crossref","first-page":"675","DOI":"10.5603\/CJ.2011.0032","volume":"18","author":"JJ Chen","year":"2011","unstructured":"Chen JJ, Zhou SH (2011) Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT\/ERK-related pathway. Cardiol J 18:675\u2013681","journal-title":"Cardiol J"},{"key":"9576_CR74","doi-asserted-by":"crossref","first-page":"484","DOI":"10.3892\/ijmm.2012.1200","volume":"31","author":"F Huang","year":"2013","unstructured":"Huang F, Zhu X, Hu XQ, Fang ZF, Tang L, Lu XL, Zhou SH (2013) Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival. Int J Mol Med 31:484\u2013492","journal-title":"Int J Mol Med"},{"key":"9576_CR75","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1582-4934.2010.01104.x","volume":"15","author":"J Liu","year":"2011","unstructured":"Liu J, van Mil A, Vrijsen K, Zhao J, Gao L, Metz CH, Goumans MJ, Doevendans PA, Sluijter JP (2011) MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1. J Cell Mol Med 15:1474\u20131482","journal-title":"J Cell Mol Med"},{"key":"9576_CR76","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrcardio.2014.207","volume":"12","author":"RA Boon","year":"2015","unstructured":"Boon RA, Dimmeler S (2015) MicroRNAs in myocardial infarction. Nat Rev Cardiol 12:135\u2013142","journal-title":"Nat Rev Cardiol"},{"key":"9576_CR77","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/j.jacc.2012.02.033","volume":"59","author":"Q Xu","year":"2012","unstructured":"Xu Q, Seeger FH, Castillo J, Iekushi K, Boon RA, Farcas R, Manavski Y, Li YG, Assmus B, Zeiher AM, Dimmeler S (2012) Micro-RNA-34a contributes to the impaired function of bone marrow-derived mononuclear cells from patients with cardiovascular disease. J Am Coll Cardiol 59:2107\u20132117","journal-title":"J Am Coll Cardiol"},{"key":"9576_CR78","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1101\/gad.1738708","volume":"22","author":"N Liu","year":"2008","unstructured":"Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R, Olson EN (2008) microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 22:3242\u20133254","journal-title":"Genes Dev"},{"key":"9576_CR79","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCRESAHA.109.202176","volume":"106","author":"SJ Matkovich","year":"2010","unstructured":"Matkovich SJ, Wang W, Tu Y, Eschenbacher WH, LE Dorn, Condorelli G, Diwan A, Nerbonne JM, Dorn GN (2010) MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res 106:166\u2013175","journal-title":"Circ Res"},{"key":"9576_CR80","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.stemcr.2014.10.010","volume":"3","author":"A Izarra","year":"2014","unstructured":"Izarra A, Moscoso I, Levent E, Canon S, Cerrada I, Diez-Juan A, Blanca V, Nunez-Gil IJ, Valiente I, Ruiz-Sauri A, Sepulveda P, Tiburcy M, Zimmermann WH, Bernad A (2014) miR-133a enhances the protective capacity of cardiac progenitors cells after myocardial infarction. Stem Cell Rep 3:1029\u20131042","journal-title":"Stem Cell Rep"},{"key":"9576_CR81","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00281-010-0233-9","volume":"33","author":"N Chaput","year":"2011","unstructured":"Chaput N, Thery C (2011) Exosomes: immune properties and potential clinical implementations. Semin Immunopathol 33:419\u2013440","journal-title":"Semin Immunopathol"},{"key":"9576_CR82","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nri2567","volume":"9","author":"C Thery","year":"2009","unstructured":"Thery C, Ostrowski M, Segura E (2009) Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9:581\u2013593","journal-title":"Nat Rev Immunol"},{"key":"9576_CR83","doi-asserted-by":"crossref","first-page":"e34653","DOI":"10.1371\/journal.pone.0034653","volume":"7","author":"A Waldenstrom","year":"2012","unstructured":"Waldenstrom A, Genneback N, Hellman U, Ronquist G (2012) Cardiomyocyte microvesicles contain DNA\/RNA and convey biological messages to target cells. PLoS One 7:e34653","journal-title":"PLoS One"},{"key":"9576_CR84","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri3622","volume":"14","author":"PD Robbins","year":"2014","unstructured":"Robbins PD, Morelli AE (2014) Regulation of immune responses by extracellular vesicles. Nat Rev Immunol 14:195\u2013208","journal-title":"Nat Rev Immunol"},{"key":"9576_CR85","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/j.bbapap.2013.01.032","volume":"1834","author":"M Makridakis","year":"2013","unstructured":"Makridakis M, Roubelakis MG, Vlahou A (2013) Stem cells: insights into the secretome. Biochim Biophys Acta 1834:2380\u20132384","journal-title":"Biochim Biophys Acta"},{"key":"9576_CR86","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCRESAHA.109.210682","volume":"106","author":"I Chimenti","year":"2010","unstructured":"Chimenti I, Smith RR, Li TS, Gerstenblith G, Messina E, Giacomello A, Marban E (2010) Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 106:971\u2013980","journal-title":"Circ Res"},{"key":"9576_CR87","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1096\/fj.05-5211com","volume":"20","author":"M Gnecchi","year":"2006","unstructured":"Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, Mu H, Melo LG, Pratt RE, Ingwall JS, Dzau VJ (2006) Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J 20:661\u2013669","journal-title":"FASEB J"},{"key":"9576_CR88","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","volume":"4","author":"RC Lai","year":"2010","unstructured":"Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, Salto-Tellez M, Timmers L, Lee CN, El OR, Pasterkamp G, de Kleijn DP, Lim SK (2010) Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury. Stem Cell Res 4:214\u2013222","journal-title":"Stem Cell Res"},{"key":"9576_CR89","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.bbrc.2013.01.015","volume":"431","author":"L Chen","year":"2013","unstructured":"Chen L, Wang Y, Pan Y, Zhang L, Shen C, Qin G, Ashraf M, Weintraub N, Ma G, Tang Y (2013) Cardiac progenitor-derived exosomes protect ischemic myocardium from acute ischemia\/reperfusion injury. Biochem Biophys Res Commun 431:566\u2013571","journal-title":"Biochem Biophys Res Commun"},{"key":"9576_CR90","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","volume":"2","author":"AG Ibrahim","year":"2014","unstructured":"Ibrahim AG, Cheng K, Marban E (2014) Exosomes as critical agents of cardiac regeneration triggered by cell therapy. Stem Cell Rep 2:606\u2013619","journal-title":"Stem Cell Rep"},{"key":"9576_CR91","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.scr.2013.01.002","volume":"10","author":"F Arslan","year":"2013","unstructured":"Arslan F, Lai RC, Smeets MB, Akeroyd L, Choo A, Aguor ENE, Timmers L, van Rijen HV, Doevendans PA, Pasterkamp G, Lim SK, de Kleijn DP (2013) Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K\/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia\/reperfusion injury. Stem Cell Res 10:301\u2013312","journal-title":"Stem Cell Res"},{"key":"9576_CR92","doi-asserted-by":"crossref","first-page":"e88685","DOI":"10.1371\/journal.pone.0088685","volume":"9","author":"Y Feng","year":"2014","unstructured":"Feng Y, Huang W, Wani M, Yu X, Ashraf M (2014) Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS One 9:e88685","journal-title":"PLoS One"},{"key":"9576_CR93","doi-asserted-by":"crossref","first-page":"H1723","DOI":"10.1152\/ajpheart.00553.2011","volume":"301","author":"S Sanada","year":"2011","unstructured":"Sanada S, Komuro I, Kitakaze M (2011) Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures. Am J Physiol Heart Circ Physiol 301:H1723\u2013H1741","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9576_CR94","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/cvr\/cvs096","volume":"94","author":"X Wang","year":"2012","unstructured":"Wang X, Zhu H, Zhang X, Liu Y, Chen J, Medvedovic M, Li H, Weiss MJ, Ren X, Fan GC (2012) Loss of the miR-144\/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res 94:379\u2013390","journal-title":"Cardiovasc Res"},{"key":"9576_CR95","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yjmcc.2014.01.004","volume":"68","author":"Z Giricz","year":"2014","unstructured":"Giricz Z, Varga ZV, Baranyai T, Sipos P, Paloczi K, Kittel A, Buzas EI, Ferdinandy P (2014) Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles. J Mol Cell Cardiol 68:75\u201378","journal-title":"J Mol Cell Cardiol"},{"key":"9576_CR96","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijcard.2014.10.144","volume":"178","author":"T Yamaguchi","year":"2015","unstructured":"Yamaguchi T, Izumi Y, Nakamura Y, Yamazaki T, Shiota M, Sano S, Tanaka M, Osada-Oka M, Shimada K, Miura K, Yoshiyama M, Iwao H (2015) Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction. Int J Cardiol 178:239\u2013246","journal-title":"Int J Cardiol"},{"key":"9576_CR97","doi-asserted-by":"crossref","first-page":"e73304","DOI":"10.1371\/journal.pone.0073304","volume":"8","author":"B Yu","year":"2013","unstructured":"Yu B, Gong M, Wang Y, Millard RW, Pasha Z, Yang Y, Ashraf M, Xu M (2013) Cardiomyocyte protection by GATA-4 gene engineered mesenchymal stem cells is partially mediated by translocation of miR-221 in microvesicles. PLoS One 8:e73304","journal-title":"PLoS One"},{"key":"9576_CR98","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1161\/CIRCULATIONAHA.108.841155","volume":"120","author":"M Huang","year":"2009","unstructured":"Huang M, Chen Z, Hu S, Jia F, Li Z, Hoyt G, Robbins RC, Kay MA, Wu JC (2009) Novel minicircle vector for gene therapy in murine myocardial infarction. Circulation 120:S230\u2013S237","journal-title":"Circulation"},{"key":"9576_CR99","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCRESAHA.111.251546","volume":"109","author":"R Katare","year":"2011","unstructured":"Katare R, Riu F, Mitchell K, Gubernator M, Campagnolo P, Cui Y, Fortunato O, Avolio E, Cesselli D, Beltrami AP, Angelini G, Emanueli C, Madeddu P (2011) Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132. Circ Res 109:894\u2013906","journal-title":"Circ Res"},{"key":"9576_CR100","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cvr\/cvu167","volume":"103","author":"L Barile","year":"2014","unstructured":"Barile L, Lionetti V, Cervio E, Matteucci M, Gherghiceanu M, Popescu LM, Torre T, Siclari F, Moccetti T, Vassalli G (2014) Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction. Cardiovasc Res 103:530\u2013541","journal-title":"Cardiovasc Res"},{"key":"9576_CR101","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jacc.2006.06.005","volume":"48","author":"KL Christman","year":"2006","unstructured":"Christman KL, Lee RJ (2006) Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 48:907\u2013913","journal-title":"J Am Coll Cardiol"},{"key":"9576_CR102","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1161\/CIRCRESAHA.113.300216","volume":"113","author":"L Ye","year":"2013","unstructured":"Ye L, Zimmermann WH, Garry DJ, Zhang J (2013) Patching the heart: cardiac repair from within and outside. Circ Res 113:922\u2013932","journal-title":"Circ Res"},{"key":"9576_CR103","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.mayocp.2013.05.003","volume":"88","author":"M Radisic","year":"2013","unstructured":"Radisic M, Christman KL (2013) Materials science and tissue engineering: repairing the heart. Mayo Clin Proc 88:884\u2013898","journal-title":"Mayo Clin Proc"},{"key":"9576_CR104","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2217\/nnm.10.12","volume":"5","author":"H Geckil","year":"2010","unstructured":"Geckil H, Xu F, Zhang X, Moon S, Demirci U (2010) Engineering hydrogels as extracellular matrix mimics. Nanomedicine 5:469\u2013484","journal-title":"Nanomedicine"},{"key":"9576_CR105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.biomaterials.2013.09.085","volume":"35","author":"AE Mayfield","year":"2014","unstructured":"Mayfield AE, Tilokee EL, Latham N, McNeill B, Lam BK, Ruel M, Suuronen EJ, Courtman DW, Stewart DJ, Davis DR (2014) The effect of encapsulation of cardiac stem cells within matrix-enriched hydrogel capsules on cell survival, post-ischemic cell retention and cardiac function. Biomaterials 35:133\u2013142","journal-title":"Biomaterials"},{"key":"9576_CR106","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.biomaterials.2010.10.007","volume":"32","author":"Y Miyagi","year":"2011","unstructured":"Miyagi Y, Chiu LL, Cimini M, Weisel RD, Radisic M, Li RK (2011) Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. Biomaterials 32:1280\u20131290","journal-title":"Biomaterials"},{"key":"9576_CR107","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.healun.2010.03.016","volume":"29","author":"H Wang","year":"2010","unstructured":"Wang H, Zhang X, Li Y, Ma Y, Zhang Y, Liu Z, Zhou J, Lin Q, Wang Y, Duan C, Wang C (2010) Improved myocardial performance in infarcted rat heart by co-injection of basic fibroblast growth factor with temperature-responsive chitosan hydrogel. J Heart Lung Transplant 29:881\u2013887","journal-title":"J Heart Lung Transplant"},{"key":"9576_CR108","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.biomaterials.2010.08.097","volume":"32","author":"E Ruvinov","year":"2011","unstructured":"Ruvinov E, Leor J, Cohen S (2011) The promotion of myocardial repair by the sequential delivery of IGF-1 and HGF from an injectable alginate biomaterial in a model of acute myocardial infarction. Biomaterials 32:565\u2013578","journal-title":"Biomaterials"},{"key":"9576_CR109","doi-asserted-by":"crossref","first-page":"I151","DOI":"10.1161\/01.cir.0000032876.55215.10","volume":"106","author":"WH Zimmermann","year":"2002","unstructured":"Zimmermann WH, Didie M, Wasmeier GH, Nixdorff U, Hess A, Melnychenko I, Boy O, Neuhuber WL, Weyand M, Eschenhagen T (2002) Cardiac grafting of engineered heart tissue in syngenic rats. Circulation 106:I151\u2013I157","journal-title":"Circulation"},{"key":"9576_CR110","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm1394","volume":"12","author":"WH Zimmermann","year":"2006","unstructured":"Zimmermann WH, Melnychenko I, Wasmeier G, Didie M, Naito H, Nixdorff U, Hess A, Budinsky L, Brune K, Michaelis B, Dhein S, Schwoerer A, Ehmke H, Eschenhagen T (2006) Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat Med 12:452\u2013458","journal-title":"Nat Med"},{"key":"9576_CR111","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/01.RES.0000209515.59115.70","volume":"98","author":"A Furuta","year":"2006","unstructured":"Furuta A, Miyoshi S, Itabashi Y, Shimizu T, Kira S, Hayakawa K, Nishiyama N, Tanimoto K, Hagiwara Y, Satoh T, Fukuda K, Okano T, Ogawa S (2006) Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart, in vivo. Circ Res 98:705\u2013712","journal-title":"Circ Res"},{"key":"9576_CR112","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1089\/ten.2006.0359","volume":"13","author":"RK Birla","year":"2007","unstructured":"Birla RK, Huang YC, Dennis RG (2007) Development of a novel bioreactor for the mechanical loading of tissue-engineered heart muscle. Tissue Eng 13:2239\u20132248","journal-title":"Tissue Eng"},{"key":"9576_CR113","doi-asserted-by":"crossref","first-page":"204173141245535","DOI":"10.1177\/2041731412455354","volume":"3","author":"RA Lasher","year":"2012","unstructured":"Lasher RA, Pahnke AQ, Johnson JM, Sachse FB, Hitchcock RW (2012) Electrical stimulation directs engineered cardiac tissue to an age-matched native phenotype. J Tissue Eng 3:2041731412455354","journal-title":"J Tissue Eng"},{"key":"9576_CR114","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1089\/ten.tea.2013.0355","volume":"20","author":"KY Morgan","year":"2014","unstructured":"Morgan KY, Black LR (2014) Mimicking isovolumic contraction with combined electromechanical stimulation improves the development of engineered cardiac constructs. Tissue Eng Part A 20:1654\u20131667","journal-title":"Tissue Eng Part A"},{"key":"9576_CR115","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1016\/j.jacc.2011.11.001","volume":"58","author":"AA Rane","year":"2011","unstructured":"Rane AA, Christman KL (2011) Biomaterials for the treatment of myocardial infarction: a 5-year update. J Am Coll Cardiol 58:2615\u20132629","journal-title":"J Am Coll Cardiol"},{"key":"9576_CR116","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jacc.2004.04.040","volume":"44","author":"KL Christman","year":"2004","unstructured":"Christman KL, Vardanian AJ, Fang Q, Sievers RE, Fok HH, Lee RJ (2004) Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 44:654\u2013660","journal-title":"J Am Coll Cardiol"},{"key":"9576_CR117","doi-asserted-by":"crossref","first-page":"e6005","DOI":"10.1371\/journal.pone.0006005","volume":"4","author":"JS Nakamuta","year":"2009","unstructured":"Nakamuta JS, Danoviz ME, Marques FL, Dos SL, Becker C, Goncalves GA, Vassallo PF, Schettert IT, Tucci PJ, Krieger JE (2009) Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold. PLoS One 4:e6005","journal-title":"PLoS One"},{"key":"9576_CR118","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1089\/ten.tea.2010.0124","volume":"17","author":"HD Guo","year":"2011","unstructured":"Guo HD, Wang HJ, Tan YZ, Wu JH (2011) Transplantation of marrow-derived cardiac stem cells carried in fibrin improves cardiac function after myocardial infarction. Tissue Eng Part A 17:45\u201358","journal-title":"Tissue Eng Part A"},{"key":"9576_CR119","doi-asserted-by":"crossref","first-page":"e12077","DOI":"10.1371\/journal.pone.0012077","volume":"5","author":"ME Danoviz","year":"2010","unstructured":"Danoviz ME, Nakamuta JS, Marques FL, Dos SL, Alvarenga EC, Dos SA, Antonio EL, Schettert IT, Tucci PJ, Krieger JE (2010) Rat adipose tissue-derived stem cells transplantation attenuates cardiac dysfunction post infarction and biopolymers enhance cell retention. PLoS One 5:e12077","journal-title":"PLoS One"},{"key":"9576_CR120","doi-asserted-by":"crossref","first-page":"I173","DOI":"10.1161\/CIRCULATIONAHA.104.526178","volume":"112","author":"T Kofidis","year":"2005","unstructured":"Kofidis T, Lebl DR, Martinez EC, Hoyt G, Tanaka M, Robbins RC (2005) Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury. Circulation 112:I173\u2013I177","journal-title":"Circulation"},{"key":"9576_CR121","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1016\/j.actbio.2009.04.040","volume":"5","author":"T Wang","year":"2009","unstructured":"Wang T, Jiang XJ, Tang QZ, Li XY, Lin T, Wu DQ, Zhang XZ, Okello E (2009) Bone marrow stem cells implantation with alpha-cyclodextrin\/MPEG-PCL-MPEG hydrogel improves cardiac function after myocardial infarction. Acta Biomater 5:2939\u20132944","journal-title":"Acta Biomater"},{"key":"9576_CR122","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2015.02.009","volume":"203","author":"S Pascual-Gil","year":"2015","unstructured":"Pascual-Gil S, Garbayo E, Diaz-Herraez P, Prosper F, Blanco-Prieto MJ (2015) Heart regeneration after myocardial infarction using synthetic biomaterials. J Control Release 203:23\u201338","journal-title":"J Control Release"},{"key":"9576_CR123","doi-asserted-by":"crossref","first-page":"11507","DOI":"10.1073\/pnas.1004097107","volume":"107","author":"JL Ifkovits","year":"2010","unstructured":"Ifkovits JL, Tous E, Minakawa M, Morita M, Robb JD, Koomalsingh KJ, Gorman JR, Gorman RC, Burdick JA (2010) Injectable hydrogel properties influence infarct expansion and extent of postinfarction left ventricular remodeling in an ovine model. Proc Natl Acad Sci USA 107:11507\u201311512","journal-title":"Proc Natl Acad Sci USA"},{"key":"9576_CR124","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.106.657270","volume":"114","author":"ST Wall","year":"2006","unstructured":"Wall ST, Walker JC, Healy KE, Ratcliffe MB, Guccione JM (2006) Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 114:2627\u20132635","journal-title":"Circulation"},{"key":"9576_CR125","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s12265-011-9291-1","volume":"4","author":"E Tous","year":"2011","unstructured":"Tous E, Purcell B, Ifkovits JL, Burdick JA (2011) Injectable acellular hydrogels for cardiac repair. J Cardiovasc Transl Res 4:528\u2013542","journal-title":"J Cardiovasc Transl Res"},{"key":"9576_CR126","first-page":"146ra109","volume":"4","author":"YD Lin","year":"2012","unstructured":"Lin YD, Luo CY, Hu YN, Yeh ML, Hsueh YC, Chang MY, Tsai DC, Wang JN, Tang MJ, Wei EI, Springer ML, Hsieh PC (2012) Instructive nanofiber scaffolds with VEGF create a microenvironment for arteriogenesis and cardiac repair. Sci Transl Med 4:146ra109","journal-title":"Sci Transl Med"},{"key":"9576_CR127","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1016\/j.biomaterials.2004.09.042","volume":"26","author":"VM Tatard","year":"2005","unstructured":"Tatard VM, Venier-Julienne MC, Saulnier P, Prechter E, Benoit JP, Menei P, Montero-Menei CN (2005) Pharmacologically active microcarriers: a tool for cell therapy. Biomaterials 26:3727\u20133737","journal-title":"Biomaterials"},{"key":"9576_CR128","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejpb.2008.03.006","volume":"70","author":"A Giteau","year":"2008","unstructured":"Giteau A, Venier-Julienne MC, Marchal S, Courthaudon JL, Sergent M, Montero-Menei C, Verdier JM, Benoit JP (2008) Reversible protein precipitation to ensure stability during encapsulation within PLGA microspheres. Eur J Pharm Biopharm 70:127\u2013136","journal-title":"Eur J Pharm Biopharm"},{"key":"9576_CR129","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/cvr\/cvv197","volume":"108","author":"R Madonna","year":"2015","unstructured":"Madonna R, Petrov L, Teberino MA, Manzoli L, Karam JP, Renna FV, Ferdinandy P, Montero-Menei CN, Yla-Herttuala S, De Caterina R (2015) Transplantation of adipose tissue mesenchymal cells conjugated with VEGF-releasing microcarriers promotes repair in murine myocardial infarction. Cardiovasc Res 108:39\u201349","journal-title":"Cardiovasc Res"},{"key":"9576_CR130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1083-8791(99)70010-8","volume":"5","author":"ED Thomas","year":"1999","unstructured":"Thomas ED, Blume KG (1999) Historical markers in the development of allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant 5:341\u2013346","journal-title":"Biol Blood Marrow Transplant"},{"key":"9576_CR131","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.jacc.2010.06.041","volume":"56","author":"LM Buja","year":"2010","unstructured":"Buja LM, Vela D (2010) Immunologic and inflammatory reactions to exogenous stem cells: implications for experimental studies and clinical trials for myocardial repair. J Am Coll Cardiol 56:1693\u20131700","journal-title":"J Am Coll Cardiol"},{"key":"9576_CR132","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature10135","volume":"474","author":"T Zhao","year":"2011","unstructured":"Zhao T, Zhang Z, Rong Z, Xu Y (2011) Immunogenicity of induced pluripotent stem cells. Nature 474:212\u2013215","journal-title":"Nature"},{"key":"9576_CR133","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjcard.2004.03.034","volume":"94","author":"SL Chen","year":"2004","unstructured":"Chen SL, Fang WW, Ye F, Liu YH, Qian J, Shan SJ, Zhang JJ, Chunhua RZ, Liao LM, Lin S, Sun JP (2004) Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 94:92\u201395","journal-title":"Am J Cardiol"},{"key":"9576_CR134","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/01.tp.0000258649.23081.a3","volume":"83","author":"AJ Poncelet","year":"2007","unstructured":"Poncelet AJ, Vercruysse J, Saliez A, Gianello P (2007) Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo. Transplantation 83:783\u2013790","journal-title":"Transplantation"},{"key":"9576_CR135","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","volume":"111","author":"GM Spaggiari","year":"2008","unstructured":"Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L (2008) Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood 111:1327\u20131333","journal-title":"Blood"},{"key":"9576_CR136","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nm.1905","volume":"15","author":"K Nemeth","year":"2009","unstructured":"Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E (2009) Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med 15:42\u201349","journal-title":"Nat Med"},{"key":"9576_CR137","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1161\/CIRCULATIONAHA.112.000324","volume":"128","author":"S Dhingra","year":"2013","unstructured":"Dhingra S, Li P, Huang XP, Guo J, Wu J, Mihic A, Li SH, Zang WF, Shen D, Weisel RD, Singal PK, Li RK (2013) Preserving prostaglandin E2 level prevents rejection of implanted allogeneic mesenchymal stem cells and restores postinfarction ventricular function. Circulation 128:S69\u2013S78","journal-title":"Circulation"},{"key":"9576_CR138","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.stem.2012.05.005","volume":"10","author":"S Yamanaka","year":"2012","unstructured":"Yamanaka S (2012) Induced pluripotent stem cells: past, present, and future. Cell Stem Cell 10:678\u2013684","journal-title":"Cell Stem Cell"},{"key":"9576_CR139","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCRESAHA.111.256149","volume":"112","author":"H Okano","year":"2013","unstructured":"Okano H, Nakamura M, Yoshida K, Okada Y, Tsuji O, Nori S, Ikeda E, Yamanaka S, Miura K (2013) Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res 112:523\u2013533","journal-title":"Circ Res"},{"key":"9576_CR140","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.stem.2013.01.006","volume":"12","author":"P Guha","year":"2013","unstructured":"Guha P, Morgan JW, Mostoslavsky G, Rodrigues NP, Boyd AS (2013) Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. Cell Stem Cell 12:407\u2013412","journal-title":"Cell Stem Cell"},{"key":"9576_CR141","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature11807","volume":"494","author":"R Araki","year":"2013","unstructured":"Araki R, Uda M, Hoki Y, Sunayama M, Nakamura M, Ando S, Sugiura M, Ideno H, Shimada A, Nifuji A, Abe M (2013) Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 494:100\u2013104","journal-title":"Nature"},{"key":"9576_CR142","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.stem.2013.03.008","volume":"12","author":"S Kaneko","year":"2013","unstructured":"Kaneko S, Yamanaka S (2013) To be immunogenic, or not to be: that\u2019s the iPSC question. Cell Stem Cell 12:385\u2013386","journal-title":"Cell Stem Cell"},{"key":"9576_CR143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13238-013-0003-2","volume":"5","author":"J Cao","year":"2014","unstructured":"Cao J, Li X, Lu X, Zhang C, Yu H, Zhao T (2014) Cells derived from iPSC can be immunogenic\u2014yes or no? Protein Cell 5:1\u20133","journal-title":"Protein Cell"},{"key":"9576_CR144","doi-asserted-by":"crossref","first-page":"8718","DOI":"10.1073\/pnas.0915086107","volume":"107","author":"KM Dhodapkar","year":"2010","unstructured":"Dhodapkar KM, Feldman D, Matthews P, Radfar S, Pickering R, Turkula S, Zebroski H, Dhodapkar MV (2010) Natural immunity to pluripotency antigen OCT4 in humans. Proc Natl Acad Sci USA 107:8718\u20138723","journal-title":"Proc Natl Acad Sci USA"},{"key":"9576_CR145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12015-014-9574-4","volume":"11","author":"S Solomon","year":"2015","unstructured":"Solomon S, Pitossi F, Rao MS (2015) Banking on iPSC- Is it Doable and is it Worthwhile. Stem Cell Rev Rep 11:1\u201310","journal-title":"Stem Cell Rev Rep"},{"key":"9576_CR146","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, Hong H, Nakagawa M, Tanabe K, Tezuka K, Shibata T, Kunisada T, Takahashi M, Takahashi J, Saji H, Yamanaka S (2011) A more efficient method to generate integration-free human iPS cells. Nat Methods 8:409\u2013412","journal-title":"Nat Methods"},{"key":"9576_CR147","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.stem.2012.07.014","volume":"11","author":"CJ Taylor","year":"2012","unstructured":"Taylor CJ, Peacock S, Chaudhry AN, Bradley JA, Bolton EM (2012) Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell 11:147\u2013152","journal-title":"Cell Stem Cell"},{"key":"9576_CR148","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(05)67813-0","volume":"366","author":"CJ Taylor","year":"2005","unstructured":"Taylor CJ, Bolton EM, Pocock S, Sharples LD, Pedersen RA, Bradley JA (2005) Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet 366:2019\u20132025","journal-title":"Lancet"},{"key":"9576_CR149","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S1674-8301(11)60044-4","volume":"25","author":"Q Pan","year":"2011","unstructured":"Pan Q, Fan S, Wang X, Zhao X, Pan M, Wang C, Shen J (2011) The distribution of HLA-A, -B, and -DRB1 alleles and haplotypes in inhabitants of Guizhou Province of China. J Biomed Res 25:328\u2013334","journal-title":"J Biomed Res"},{"key":"9576_CR150","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nbt.2973","volume":"32","author":"PW Andrews","year":"2014","unstructured":"Andrews PW, Cavagnaro J, Deans R, Feigal E, Horowitz E, Keating A, Rao M, Turner M, Wilmut I, Yamanaka S (2014) Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells. Nat Biotechnol 32:724\u2013726","journal-title":"Nat Biotechnol"},{"key":"9576_CR151","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.1200708","volume":"331","author":"ER Porrello","year":"2011","unstructured":"Porrello ER, Mahmoud AI, Simpson E, Hill JA, Richardson JA, Olson EN, Sadek HA (2011) Transient regenerative potential of the neonatal mouse heart. Science 331:1078\u20131080","journal-title":"Science"},{"key":"9576_CR152","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1073\/pnas.1208863110","volume":"110","author":"ER Porrello","year":"2013","unstructured":"Porrello ER, Mahmoud AI, Simpson E, Johnson BA, Grinsfelder D, Canseco D, Mammen PP, Rothermel BA, Olson EN, Sadek HA (2013) Regulation of neonatal and adult mammalian heart regeneration by the miR-15 family. Proc Natl Acad Sci USA 110:187\u2013192","journal-title":"Proc Natl Acad Sci USA"},{"key":"9576_CR153","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1111\/jcmm.12421","volume":"18","author":"L Rui","year":"2014","unstructured":"Rui L, Yu N, Hong L, Feng H, Chunyong H, Jian M, Zhe Z, Shengshou H (2014) Extending the time window of mammalian heart regeneration by thymosin beta 4. J Cell Mol Med 18:2417\u20132424","journal-title":"J Cell Mol Med"},{"key":"9576_CR154","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nrcardio.2014.207-c1","volume":"12","author":"Y Li","year":"2015","unstructured":"Li Y, Shen Z, Yu X (2015) Transport of microRNAs via exosomes. Nat Rev Cardiol 12:198","journal-title":"Nat Rev Cardiol"},{"key":"9576_CR155","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJA (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29:341\u2013345","journal-title":"Nat Biotechnol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-016-9576-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-016-9576-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-016-9576-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T13:05:25Z","timestamp":1718715925000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-016-9576-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,26]]},"references-count":155,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["9576"],"URL":"https:\/\/doi.org\/10.1007\/s10741-016-9576-1","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,26]]}}}